Opioid Addiction in Tennessee

Slides:



Advertisements
Similar presentations
A Powerful Tool May, 2014 PDMP. pdmp No reportable financial interest.
Advertisements

Single State Agency responsible for planning, coordination and regulation of the statewide network of prevention, intervention, treatment and recovery.
Youth Mental Health April 9, Overview History Current Youth Mental Health Resources – Wraparound Orange Youth Mental Health Proposal Action item.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Project Lazarus/CCNC A statewide initiative to prevent drug overdose Dr. Robin Gary Cummings Deputy Secretary for Health Services State Health Director.
Incorporating Data into a Needs Assessment Tennessee Department of Mental Health and Substance Abuse Services Office of Planning Office of Research.
Neonatal Abstinence Syndrome (NAS) Prevention Toolkit
COMING UP ROSES: CULTIVATING A CONTINUUM OF SERVICES FOR PREVENTION, DIAGNOSIS AND TREATMENT OF FETAL ALCOHOL SPECTRUM DISORDERS IN THE GARDEN STATE Susan.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Addressing the Substance Abuse Epidemic in Tennessee
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
D B H D S Virginia Department of Behavioral Health and Developmental Services Creating Opportunities for People with Substance Use Disorders a presentation.
1. 2 National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) Established 1976.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
One Care of SWVA A Consortium of Substance Abuse Coalitions Sarah T. Melton, PharmD,BCACP,BCPP, FASCP Chair, One Care
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Nebraska’s Prescription Drug Monitoring Program What Do I Really Need to Know? Amy Reynoldson, DHHS Kevin C. Borcher, PharmD,NeHII, Inc.
Overview of Substance Abuse Prevention Rebecca Alfaro Deputy Executive Director New Jersey Governor’s Council on Alcoholism and Drug Abuse.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Addiction State Representative Robert Cole Sprague 83 rd Ohio House District.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
Substance Exposed Newborns: Addressing Substance Use Disorder
Current Concepts in Pain Management
State Targeted Response to Opioid Crisis
Initiatives Toward A Public Health Approach
OPIOID EPIDEMIC.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
5th Annual Empowering Local Leadership Conference
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Barbara Sears, Director Ohio Department of Medicaid November 8, 2017
Understanding the Opioid Epidemic
Opioid Crisis A Call to ACTION
Addiction and the Opioid Crisis: HHS Update
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
21st Century Prevention Amid the Opioid Crisis
The Overdose Epidemic in RI:
SAMHSA Resources to Address the Opioid Epidemic
CSAT Taking Action: 2018 Snapshot
MDHHS Response to the Opioid Crisis
Managing the Opioid Epidemic in Louisiana Together We Can
Primary Prevention in the Time of the Opioid Epidemic
The Opioid Epidemic: Crisis in the Workplace
Recovery Residences - Florida
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioid-related harms and responses
Pain Management and Substance Use Disorders: JCPP Strategic Session
Jim Langford – Georgia Prevention Project November 5, 2018
Our Vision and Mission Vision Mission Goal
The Overdose Epidemic in RI:
NJ Cares Initiatives Impact on Municipalities
West Virginia Medicaid Summit
SAMHSA’S FY 2018 BUDGET As Proposed in the President’s Budget.
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Substance Use Prevention for Young Adults and Higher Education
Community-Based Strategies for Preventing Opioid Abuse
Strategic Initiatives to Address Opioid Overdose & Addiction
Colorado Opioid Task Force
National and State Data
Presentation transcript:

Opioid Addiction in Tennessee State of Tennessee House of Representatives Task Force on Opioid Abuse February 23, 2017 Rodney Bragg, Assistant Commissioner for Substance Abuse Services Stephen Loyd, M.D., Medical Director for Substance Abuse Services

Addiction is a Disease, Not a Moral Failure The Science of Addiction

Addiction is a Disease, Not a Moral Failure

Addiction is a Disease, Not a Moral Failure Hi-Jacking of the Limbic (Reward) System

Addiction is a Disease, Not a Moral Failure Brain Healing Takes Time

Addiction is a Disease, Not a Moral Failure Source: Surgeon General’s Special Report: Facing Addiction in America Chapter 2

How Did We Get Here? Decade of chronic pain epidemic (1990s); Joint Commission “Pain as the 5th vital sign” Marketing of opioids as having a low addictive potential when used for the treatment of chronic pain Result: Opioids prescribed more freely by practitioners Tennessee Impact: Increase in doctor shopping Increase in morphine milligram equivalents (MMEs) prescribed Increase in prescriptions dispensed Increase in number of people seeking treatment for opioid use disorder Increase in improper prescribing (pill mills) Increase in number of people in the criminal justice system for drug-related offenses Increase in number of babies born drug dependent Increase in overdose deaths

Tennessee’s Response to the Opioid Epidemic

How Many Tennesseans are Affected? In Tennessee, it is estimated that 69,100 individuals are addicted to prescription opioids and require treatment for prescription opioid abuse. Another 151,900 Tennesseans are using prescription opioids in ways that could be harmful, and they may benefit from early intervention strategies. Source: National Survey on Drug Use and Health

Prescription for Success – Summer 2014 Tennessee’s Response Prescription for Success – Summer 2014 7 Goals Decrease the number of Tennesseans who abuse controlled substances Decrease the number of Tennesseans who overdose on controlled substances Decrease the amount of controlled substances dispensed in Tennessee Increase access to drug disposal outlets in Tennessee Increase access to and quality of early intervention, treatment, and recovery services Expand collaborations and coordination among state agencies Expand collaborations and coordination with other states

Tennessee’s Response Successes: Funded 10 additional anti-drug coalitions for a total of 43. Increased prevention efforts by reaching 6 million Tennesseans through the Take Only as Directed advertising campaign. Decreased prescription opioid seizures, crimes, and arrestees. Source: Tennessee Department of Mental Health and Substance Abuse Services Tennessee Bureau of Investigation

Tennessee’s Response Successes: Decreased opioid prescriptions by 1.1 billion morphine milligram equivalents (MMEs). Amount of morphine milligram equivalents (MMEs)1 dispensed to Tennessee patients (in millions) and reported to the Controlled Substance Monitoring Database: 2012-2015 Source: Tennessee Department of Health

221 Tennessee’s Response 106 36 Successes: Increased the number of permanent drug collection boxes from 36 boxes in 2012 to 221 boxes in 2017 – all 95 counties are covered. Source: Tennessee Department of Mental Health and Substance Abuse Services and Tennessee Department of Environment and Conservation 36 Collection boxes January 2012 106 Collection boxes December 2014 221 Collection boxes June 30, 2016

Tennessee’s Response Successes: Increased funding for a total of 54 recovery drug courts Increased recovery drug court enrollees from 1,405 in 2013 to 4,884 in 2016 – an increase of 248% Certified 180 faith-based “Recovery Congregations/Organizations” Increased funding to expand the number of Oxford Houses – sober living environments – from 6 in 2013 to 50 in 2016 with a capacity of 298 beds Source: Tennessee Department of Mental Health and Substance Abuse Services

Tennessee’s Response Successes: Conducted 2,466 Lifeline recovery trainings, established 290 new recovery meetings, and referred 1,002 people to treatment Recovery group meetings established by Lifeline: September 2013-July 2016 Source: Tennessee Department of Mental Health and Substance Abuse Services 290 Sep 2013 to Jun 2016 172 Sep 2013 to Jun 2015 61 Sep 2013 to Jun 2014

Tennessee’s Response Successes: Conducted over 39,000 Screening, Brief, Intervention, and Referral to Treatment (SBIRT) from 2012 to 2016 in primary care settings In FY 2016, served 12,191 individuals in state-funded clinical treatment services Source: Tennessee Department of Mental Health and Substance Abuse Services Substance Abuse Prevention and Treatment Block Grant FY 2016 - 2017 Annual Report

Tennessee’s Response The Tennessee General Assembly: Passed the Prescription Safety Acts of 2012 and 2016 requiring: Provider education on proper prescribing Query of the Controlled Substances Monitoring Database (CSMD) Reporting to the CSMD Repealed the Intractable Pain Act in 2015 Passed the Addiction Treatment Act of 2015, which includes a Good Samaritan Law assuring people helping others are not charged with a crime. Passed the Ensuring Patient Access to Pharmacy Drug Disposal Programs Act of 2015, allowing pharmacies to participate in drug collection programs. Passed legislation establishing regulations for Pain Clinics and Office-Based Opioid Treatment Clinics

Tennessee’s Response Other General Assembly Actions: Funding for Lifeline Program Funding additional Recovery Drug Courts Increased funding for naloxone programs

Additional Outcomes

substance use disorder. Promising Trends Show a Decrease in Tennessee Adolescent Substance Abuse Substance use declined among Tennessee youth from 2004-2006 to 2012-2014 Illicit drug use dropped from 6% to 3% Alcohol use declined from 14% to 10% Misuse of pain relievers dropped from 9% to 5% Cigarette use declined from 13% to 7% The later in life a person waits to use substances, the less likely the person is to develop a substance use disorder. Source: Tennessee Department of Mental Health and Substance Abuse Services, Strategic Prevention Framework and Substance Abuse and Mental Health Services Administration American Society of Addiction Medicine

What Tennessee is Doing Works Includes Tennessee Tennessee has mandatory prescriber education, opioid prescribing guidelines, pain clinic and office-based opioid treatment regulation, a controlled substance monitoring database, and access to naloxone. But, we need more funding to meet the need. Source: National Safety Council Report Card, 2016

Disturbing Trend – Increase in Heroin Use Heroin rates are highest in urban areas Source: Tennessee Bureau of Investigation (TBI) CJIS Support Center, 2014-2015

Disturbing Trend – Fentanyl Can You Tell the Difference?

The Substance Abuse Treatment Gap Due to a Lack of Funding, Most People in Need of Substance Abuse Treatment Do Not Receive It Source: Centers for Disease Control and Prevention and National Survey on Drug Use and Health

Potential New Resources

Potential New Resources 21st Century Cures Act Tennessee is likely to receive $13.8 million per year for 2 years for a total of $27.6 million If received, treatment services that will be funded include: Continuum of Care Treatment Services Treatment for Pregnant Women Tele-treatment in Rural Tennessee Counties Medication Assisted Treatment Recovery Support Services This treatment funding will serve an additional 5,038 – 10,534 Tennesseans based on types of services provided. Other services funded will include: Naloxone Training and Distribution Regional Overdose Prevention Specialists Media Campaign

Potential New Resources Governor Haslam’s Recommended FY 2018 Budget $6 million, new recurring state dollars, to expand substance abuse treatment services This expansion will serve an additional 1,565 – 4,380 Tennesseans yearly based on the type of services provided “In Tennessee, we know what works. We have providers standing by ready and able to do what works. Our gap is in funding.” Marie Williams Commissioner Department of Mental Health and Substance Abuse Services

Questions and Comments

For More Information Rodney Bragg Assistant Commissioner 615-532-7783 Rodney.Bragg@tn.gov Stephen Loyd, MD Medical Director for Substance Abuse Services 615-532-1225 Stephen.Loyd@tn.gov